New diabetes clinical trial: Multimodal Risk Factor Graph Mapping, Metabolic Subtyping, and Digital Intelligent Chronic Disease Management for Prediabetes: An Integrated Cohort and Case-Control Clinical Study

Published on: 2026-10-02T04:00:00Z
Conditions: Prediabetes; Prediabetes (Insulin Resistance, Impaired Glucose Tolerance); Impaired Fasting Glucose; Impaired Glucose Tolerance (Prediabetes)
Sponsors: Nanjing Medical University; The Affiliated Hospital Of Guizhou Medical University; The First Affiliated Hospital of Zhengzhou University; Suqian First Hospital; Jiangsu Taizhou People's Hospital; The First People's Hospital of Lianyungang; The Second People's Hospital of Huai'an; Wuxi People's Hospital; Nantong First People's Hospital; Yancheng First People's Hospital; The First Hospital of Jilin University; Fujian Medical University Union Hospital; Shandong Provincial Hospital; The First Affiliated Hospital of Nanchang University; People's Hospital of Xinjiang Uygur Autonomous Region; Xijing Hospital; Dalian Central Hospital; Xinqiao Hospital of Chongqing; Suzhou Municipal Hospital; Wuhu City Second People's Hospital; Shangrao People's Hospital; The Fourth Affiliated Hospital of Nanjing Medical University; Changzhou Second People's Hospital affiliated with Nanjing Medical University
Not yet recruiting
https://ift.tt/djLSsOA

Comments